IDAAM Publications

Volume 1

January-March 2023

Therapeutic and diagnostic approach of nanoparticles in biomedicine

Akshay R Yadav

Biomedicine has its own set of guidelines for implementing emerging technology for human ‎use, which is understandably conservative. Increased research has helped in the reformulation ‎of existing drugs as well as the creation of new ones. Nanotechnology changes medicine’s ‎toxicity, solubility, and bioavailability profile, among other items. However, there is still a ‎long way to go in terms of full regulation, beginning with the development of consistent ‎definitions across the board. The medicinal products come in a wide variety of forms and ‎structures, and they’ve been used to treat a wide range of acute and chronic diseases. ‎Furthermore, ongoing research is increasingly leading to the emergence of more sophisticated ‎nanostructured designs, which necessitates a detailed understanding of pharmacokinetic and ‎pharmacodynamic properties, which are determined by chemical composition and ‎physicochemical properties, poses additional regulatory challenges.‎
Keywords: Biomedicine, Nanotechnology, Medicinal Products, Nanoparticles, Nanostructured Designs‎